Advanced Wound Care Market

The advanced wound care market is expected to grow from USD 13.37 billion in 2025 to reach USD 19.32 billion by 2030, at a CAGR of 7.6% during the forecast period.

Advanced wound care products are vital for the treatment of various types of wounds, as they promote natural healing and prevent infection. These products include dressings, devices and accessories, biological skin substitutes, and topical agents, all facilitating effective healing. They are widely available and commonly used in hospitals, ambulatory surgical centers (ASCs), clinics, and home healthcare settings. By adhering to industry standards and regulatory compliance, these products help manage wounds appropriately and improve patient outcomes.

The notable companies in this market include Solventum (US), Smith+ Nephew (UK), Molnlycke AB (Sweden), Convatec Group PLC (UK), Coloplast Group (Denmark), Cardinal Health (US), Integra LifeSciences Corporation (US), PAUL HARTMANN AG (Germany), B. Braun SE (Germany), Organogenesis Inc. (US), MIMEDX Group, Inc. (US), Essity, Aktiebolag (Sweden), AVERY DENNISON CORPORATION (US), MATIV HOLDINGS, INC. (US), Owens & Minor (US), Zimmer Biomet (US), and Bioventus (US), among others—the leading companies in the market focus on higher sales, product launches, and product approvals.

To know about the assumptions considered for the study download the pdf brochure

Solventum (US)

In April 2024, after its spinoff from 3M company, Solventum began a new path as a standalone company. Although it has profited from 3M's assets and reputation in the past, it is now focusing on creating its own brand identity. To meet the needs of customers and patients, Solventum develops, produces, and markets a range of products. The company primarily operates through four business segments: MedSurg, Dental Solutions, Health Information Systems, and Purification & Filtration. Solventum focuses on innovation and strategic expansion to support growth in these areas. Integrating material science and digital capabilities enhances the company's competitive edge, leading to improved clinical and economic outcomes for healthcare providers.

Smith+Nephew (UK)

The company offers a comprehensive range of advanced wound care products, including conventional NPWT (Negative Pressure Wound Therapy) devices, single-use NPWT devices, and NPWT accessories and consumables. With a robust global market presence supported by an excellent distribution network, the company plays a vital role in improving access to healthcare in both developed and emerging economies. The company has significantly increased its focus on research and development (R&D) activities to create unique and improved products. In 2024, 2023, and 2022, it invested USD 289.0 million, USD 339.0 million, and USD 345.0 million, respectively, in R&D. This strong commitment to innovative product development has established the company as a prominent player in the advanced wound care market.

Molnlycke AB (Sweden)

With a widespread distribution network, the company has a presence across the Americas, Europe, the Asia Pacific, and the Middle East & Africa. The company opts for inorganic & organic growth strategies, such as expansion tactics, to maintain its dominant position in the market. For instance, in October 2024, Mölnlycke acquired P.G.F. Industry Solutions (Austria), the Granudacyn wound cleansing and moistening solutions manufacturer. The acquisition strengthens Mölnlycke’s wound care portfolio and expands its distribution of Granudacyn, currently available in over 50 countries.

Market Ranking

The advanced wound care market is dominated by leading players such as Solventum (US), Smith+Nephew (UK), Mölnlycke AB (Sweden), Convatec Group PLC (UK), and Coloplast Group (Denmark). These companies collectively hold 45–50% of the total market share. Smith+Nephew (UK) is a leading firm in the market through its advanced wound care solutions and strong R&D strength, enabling it to provide efficient burn care products. Mölnlycke Care AB (Sweden) asserts its market position through strategic partnerships. Convatec Group PLC (UK) has enhanced its global presence through strategic acquisitions. The market competition is driven by innovative products in advanced wound care and increasing regulatory compliance requirements.

Related Reports:

Advanced Wound Care Market by Product (Dressings (Foam, Hydrocolloid, Film), NPWT, Debridement Devices, Biological Skin Substitutes, Topical Agents), Wound Type (Surgical, Traumatic, Ulcers, Burns), End User (Hospital, Homecare), Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com